(Q24242922)

English

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

0 references

1 reference

Europe PubMed Central

title

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation (English)

0 references

main subject

irritable bowel syndrome

1 reference

1 reference

Peter J Whorwell

4

0 references

author name string

Beti W Evans

series ordinal

1

0 references

Wendy K Clark

series ordinal

2

0 references

David J Moore

series ordinal

3

0 references

publication date

17 October 2007

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Effect of a laxative with and without tegaserod in adolescents with constipation predominant irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Management of the irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Fortnightly Review: Irritable bowel, irritable body, or irritable brain?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

New drugs in the management of the irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Diagnostic criteria for the irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Irritable bowel syndrome: a little understood organic bowel disease?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

21 January 2018

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Irritable bowel syndrome: the view from general practice.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD003960.PUB3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD003960.PUB3

0 references

PubMed publication ID

17943807

0 references

(Q24242922)

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)